Cloning of a novel protein overexpressed in human mammary carcinoma

Cancer Research

Volumn 57, Issue 5, 1997, Pages 988-994

  Bachmann, Felix ^a   Ränziger, Rahel ^a   Burger, Max M ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ALIGNMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 1842413082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Weller, N. K., and Karnovsky, M. J. Identification of a 185 Kd Maclura pomifera agglutinin binding glycoprotein as a candidate for a differentiation marker for alveolar type II cells in adult rat lung. Am. J. Pathol., 134: 277-285, 1989.
2. Sadaaki, K., and Hanafusa, H. The effects of reciprocal changes in temperature on the transformed state of cells infected with a Rous sarcoma virus mutant. Virology, 46: 470-479, 1971.
3. Strickland, S., and Mahdavi, V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 15: 393-403, 1978.
4. Pierce, G. B., and Speers, W. C. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res., 48: 1996-2004, 1988.
5. Sawyers, C. L., Denny, C. T., and Witte, O. N. Leukemia and the disruption of normal hematopoiesis. Cell, 64: 337-350, 1991.
6. Sachs, L. Growth, differentiation and the reversal of malignancy. Sci. Am., 254: 30-37, 1986.
7. Sambrook, J., Fritsch, E. P., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
8. Matsudaira, P. T. (ed.). A Practical Guide to Protein and Peptide Purification for Microsequencing, pp. 17-29 and 73-85. New York: Academic Press, Inc., 1989.
9. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, pp. 92-121 and 150-312. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
10. Carrol, S. B., and Stollar, B. D. Antibodies to calf thymus RNA polymerase II from egg yolks of immunized hens. J. Biol. Chem., 258: 24-26, 1983.
11. Happ, B., Hynes, N., and Groner, B. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone-dependent activation of the mammary gland-specific transcription factor. Cell Growth & Differ., 4: 9-15, 1993.
12. Hooper, M., Hardy. K., Handyside, A., Hunter, S., and Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (Lond.), 326: 292-295, 1987.
13. Doctschmann, T., Gregg, R. G., Maeda, N., Hooper, M. L., Melton, D. W., Thompson, S., and Smithies, O. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (Lond.), 330: 576-578, 1987.
14. Williams, R. L., Hilton, D. J., Pease, S., Willson, T. A., Stewarl, C. L., Gearing, D. P., Wagner, E. F., Metcalf, D., Nicola, N. A., and Gough, N. M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (Lond.), 336: 684-690, 1988.
15. Andrews, P. W., Trinchieri, G., Perussia, B., and Baglioni, C. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. Cancer Res., 47: 740-746, 1987.
16. Lehman, J. M., Speers, W. C., Swartzendruber, D. E., and Pierce, G. B. Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma. J. Cell Physiol., 84: 13-27, 1974.
17. Solter, D., Shevinsky, L., Knowles, B. B., and Strickland, S. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev. Biol., 70:515-521, 1979.
18. O'Connor, T. J., and Fujita, D. J. Differentiation of B16 murine melanoma cells is associated with an increased level of c-SRC. Melanoma Res., 5: 5-13, 1995.
19. Tao, T. W., and Burger, M. M. Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity. Int. J. Cancer. 29: 425-430, 1982.
20. Tao, T. W., Jenkins, J. M., Vosbeck, K., Matter, A., Miller, M., Jockusch, B. M., Shen, Z. H., and Burger, M. M. Lectin-resistant variants of mouse melanoma cells. II. In vitro characteristics. Int. J. Cancer, 31: 239-247, 1983.
21. Tao, T. W., and Burger, M. M. Non-metastasising variants selected from metastasising melanoma cells. Nature (Lond.), 270: 437-438, 1977.
22. Tao, T. W., Matter, A., Vogel, K., and Burger, M. M. Liver-colonizing melanoma cells selected from B-16 melanoma. Int. J. Cancer, 23: 854-857, 1979.
23. Rusciano, D., Lorenzoni, P., and Burger, M. M. Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells. Invasion Metastasis, 13: 212-224, 1993.
24. Bennett, D. C., Dexter, T. J., Ormerod, E. J., and Hart, I. R. Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. Cancer Res., 46: 3239-3244, 1986.
25. Joswig, G., and Petzelt, C. The centrosomal cycle: visualization in PtK cells by a monoclonal antibody to a centrosomal 32 Kd protein. Cell Motil. Cytoskel., 15: 181-192, 1990.
26. Joswig, G., Petzelt, C., and Werner, D. Murine cDNAs coding for the centrosomal antigen centrosomin A. J. Cell Sci., 98: 37-43, 1991.
27. Bennett, D. C., Holmes, A., Devlin, L., and Hart, I. R. Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways. Clin. Exp. Metastasis, 12: 385-397, 1994.
28. Kameyama, K., Vieira, W. D., Tsukamoto, K., Law, L. W., and Hearing, V. J. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells. Int. J. Cancer, 45: 1151-1158, 1990.
29. Aubert, C., Voulot, C., Rouge, F., Pirisi, V., and Galindo, J. R. New variants of B16 mouse melanoma: differentiation and metastatic properties. Pigment Cell Res., 2: 17-25, 1989.
30. Hart, I. R., Goode, N. T., and Ormerod, E. J. Induction of differentiation as a means of modifying metastatic behaviour. Adv. Exp, Med. Biol., 233: 361-365, 1988.
31. Prezioso, J. A., Wang, N., Duty, L., Bloomer. W. D., and Gorelik, E. Enhancement of pulmonary metastasis formation and γ-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro. Clin. Exp. Metastasis. 11: 263-274, 1993.
32. Elston, C. W., and Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 19: 403-410, 1991.
33. Desai, C., Garriga, G., McIntire, S. L., and Horvitz, R. H. A genetic pathway for the development of the Caenorhabditis elegans HNS motor neurons. Nature (Lond.), 336: 638-646, 1988.
34. Lupas, A., Van Dyke, M., and Stock, J. Predicting coiled coils from protein sequences. Science (Washington DC), 252: 1162-1164, 1991.
35. Desai, C., and Horvitz, H. R. Caenorhabditis elegans mutants defective in functioning of the motor neurons responsible for egg laying. Genetics, 121: 703-721, 1989.